Investigation of the frequency of COVID-19 in patients treated with intravesical BCG.
Journal
Revista da Associacao Medica Brasileira (1992)
ISSN: 1806-9282
Titre abrégé: Rev Assoc Med Bras (1992)
Pays: Brazil
ID NLM: 9308586
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
06
2020
accepted:
27
06
2020
entrez:
23
9
2020
pubmed:
24
9
2020
medline:
2
10
2020
Statut:
epublish
Résumé
In this retrospective study, we aimed to investigate the frequency of COVID-19 in patients with and without BCG application due to bladder tumors. The presence of COVID-19 was investigated in 167 patients with BCG and 167 without bladder cancer. All patients were compatible with COVID-19 infection. Patients with RT-PCR positive for SARS-CoV-2 and/or Chest CT positive for viral pneumonia between March and May 2020 were included in the study. A total of 334 patients were included in the study. The mean age of the 167 patients in the study group was 71.1±14.2 1 (min. 38.0- max. 98.0 years), 141 (84.4%) were male. The mean age of the 167 patients in the control group was 70.5±13.8 years (min. 41.0- max. 96.0 years), and 149 were male (p> 0.05). COVID-19 was detected in 5 patients in the BCG group and in 4 patients in the control group (P> 0.05). Intravesical BCG administration does not decrease the frequency of COVID-19 infection.
Identifiants
pubmed: 32965364
pii: S0104-42302020001400091
doi: 10.1590/1806-9282.66.S2.91
pii:
doi:
Substances chimiques
BCG Vaccine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
91-95Commentaires et corrections
Type : CommentIn